Emerging Markets and Asia-Pacific
GSK Pharmaceuticals Emerging Markets and Asia Pacific (EMAP) Region covers seven geographical areas - Middle East and Africa, Latin America, CIS, South Asia, Developing Countries, Asia Pacific and China. Details of GSK funding provided to patient groups working in EMAP in 2012 are listed below.
All documents are in PDF format.
International
The following groups were supported by International in 2012:
International Alliance of Patient Organizations
World Hepatitis Alliance
Argentina
The following groups were supported by Argentina in 2012:
Brazil
The following group was supported by Brazil in 2012:
Brazilian Association of Lymphoma and Leukemia (ABRALE)
Chile
The following group was supported by Chile in 2012:
Colombia
The following groups were supported by Colombia in 2012:
Fundación Gestión Cultura Medellín
Fundación SIMMON
Hong Kong
The following groups were supported by Hong Kong in 2012:
Bone Health Club
Chronic Obstructive Pulmonary Disease Concern Group
The Hong Kong Arthritis & Rheumatism Foundation
The Hong Kong Asthma Society
The Hong Kong Lupus Association
Indonesia
The following group was supported by Indonesia in 2012:
Malaysia
The following group was supported by Malaysia in 2012:
New Zealand
The following group was supported by New Zealand in 2012:
Nigeria
The following group was supported by Nigeria in 2012:
Pakistan
The following group was supported by Pakistan in 2012:
Russia
The following groups were supported by Russia in 2012:
National Association of Patients with Rare Diseases
National Society of Disabled people, NSDP, Russian Diabetes Association
Russian Hemophilia Society
Ukraine
The following groups were supported by Ukraine in 2012:
Charitable Foundation Ukrainian Community Advisory Board
Rak Pobedim (Will ween the cancer)
Find out more about the groups we have supported in previous years.